Odofin explained that while emergency procedures like cesarean sections can often be performed with basic investigations, ...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets ...

Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

The reproductive organs are the key biological components that differentiate women from men. The organs include the uterus, ...

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

In an expert Q&A, Hospital for Special Surgery’s Lisa Mandl, MD, MPH, discusses the role of genicular nerve ablation in ...

The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...

Surgery and radiofrequency ablation showed similar 5-year survival rates for small liver tumors. Both treatments had nearly identical 5-year recurrence-free survival outcomes. Patient and tumor ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

The absolute difference in cancer-specific survival for thermal ablation vs surgery for T1a RCC was just 1%. Cancer-specific survival among patients with stage T1a renal cell carcinoma (RCC) is ...